Cossman J, Chused T M, Fisher R I, Magrath I, Bollum F, Jaffe E S
Cancer Res. 1983 Sep;43(9):4486-90.
Eleven cases of lymphoblastic malignancy, presenting as lymphoma, were investigated for immunological and differentiation markers prior to the onset of therapy. Biopsy specimens exhibited the typical morphological features of lymphoblastic lymphoma (convoluted T-cell lymphoma). Intranuclear terminal deoxynucleotidyl transferase was detected in the neoplastic cells from each case by indirect antibody staining of cytocentrifuge preparations. Eight cases were T-cell type as evidenced by unsensitized sheep erythrocyte rosette formation and staining with the monoclonal antibody OKT11. Three T-cell cases were OKT4 positive, two were OKT8 positive, and none were positive with both OKT4 and OKT8. Three cases failed to react with any monoclonal antibodies specific for T-cells and did not form unsensitized sheep erythrocyte rosettes or stain for surface immunoglobulin. However, these three cases were Ia positive and J5 (common acute lymphoblastic leukemia antigen) positive. Cells from two of these erythrocyte rosette-negative, Ia-positive, common acute lymphoblastic leukemia-positive cases contained intracytoplasmic mu heavy chains and were therefore of pre-B-cell phenotype. These cases were histologically indistinguishable from the T-cell cases. However, clinically, they were distinguished by the absence of mediastinal masses and by a clinical presentation as isolated lytic lesions of bone in two of the three. OKT9 and OKT10 stained neoplastic cells from T-cell, as well as pre-B-lymphoblastic, lymphoma. Although morphologically homogeneous, lymphoblastic lymphomas are comprised of an immunologically diverse group of neoplasms which include cells of "common" and "mature" thymocyte, non-T, non-B, and pre-B phenotypes and are closely related to the cells of acute lymphoblastic leukemia. In addition, intratumor heterogeneity was observed in most instances and may reflect growth or differentiation differences between subpopulations of individual neoplastic clones.
11例表现为淋巴瘤的淋巴细胞恶性肿瘤患者在治疗开始前接受了免疫和分化标志物检查。活检标本显示出淋巴细胞淋巴瘤(卷曲核T细胞淋巴瘤)的典型形态特征。通过细胞离心涂片的间接抗体染色,在每例患者的肿瘤细胞中均检测到核内末端脱氧核苷酸转移酶。8例为T细胞型,未致敏绵羊红细胞花环形成以及单克隆抗体OKT11染色可证实。3例T细胞病例OKT4阳性,2例OKT8阳性,无OKT4和OKT8均阳性者。3例与任何T细胞特异性单克隆抗体均无反应,不形成未致敏绵羊红细胞花环,也不表达表面免疫球蛋白。然而,这3例Ia阳性且J5(普通急性淋巴细胞白血病抗原)阳性。这3例红细胞花环阴性、Ia阳性、普通急性淋巴细胞白血病阳性病例中的2例细胞含有胞质内μ重链,因此为前B细胞表型。这些病例在组织学上与T细胞病例无法区分。然而,在临床上,它们的特点是无纵隔肿块,且3例中有2例表现为孤立性骨溶解性病变。OKT9和OKT10可使T细胞淋巴瘤以及前B淋巴细胞淋巴瘤的肿瘤细胞染色。虽然淋巴细胞淋巴瘤在形态上具有同质性,但它由一组免疫类型多样的肿瘤组成,包括“普通”和“成熟”胸腺细胞、非T非B以及前B表型的细胞,并且与急性淋巴细胞白血病细胞密切相关。此外,在大多数情况下观察到肿瘤内异质性,这可能反映了单个肿瘤克隆亚群之间的生长或分化差异。